In severe COVID-19, a 5-day remdesivir regimen seems as effective as a 10-day course of treatment and it may be safer. To date, the drug has no clearly proven efficacy over time.
Ippolito M., Cortegiani A. (2021). Length of remdesivir treatment in patients with severe covid-19. BREATHE, 17(1) [10.1183/20734735.0276-2020].
Length of remdesivir treatment in patients with severe covid-19
Ippolito M.;Cortegiani A.
2021-01-01
Abstract
In severe COVID-19, a 5-day remdesivir regimen seems as effective as a 10-day course of treatment and it may be safer. To date, the drug has no clearly proven efficacy over time.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Breathe.pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
85.92 kB
Formato
Adobe PDF
|
85.92 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
